Almotriptan for acute treatment of migraine: a randomized, double-blind, placebo-controlled study in Korea

被引：0
|
作者：
Chung, C. S.
Park, K. Y.
Moon, H. S.
Joo, S. A.
Song, K. S.
Kim, J. A.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Yuhan Corp, Seoul, South Korea
来源：
CEPHALALGIA | 2006年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1392 / 1392
页数：1
相关论文
共 50 条
  • [1] Haloperidol in the acute treatment of migraine: A randomized, double-blind, placebo-controlled study
    Honkaniemi, J
    Liimatainen, S
    Rainesalo, S
    Sulavuori, S
    HEADACHE, 2006, 46 (05): : 781 - 787
  • [2] Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study
    Allais, Gianni
    Bussone, Gennaro
    D'Andrea, Giovanni
    Moschiano, Franca
    d'Onofrio, Florindo
    Valguarnera, Fabio
    Manzoni, Gian Camillo
    Grazzi, Licia
    Allais, Rita
    Benedetto, Chiara
    Acuto, Giancarlo
    CEPHALALGIA, 2011, 31 (02) : 144 - 151
  • [3] Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study
    Pascual, J
    Falk, RM
    Piessens, F
    Prusinski, A
    Docekal, P
    Robert, M
    Ferrer, P
    Luria, X
    Segarra, R
    Zayas, JM
    CEPHALALGIA, 2000, 20 (06) : 588 - 596
  • [4] Randomized, double-blind, placebo-controlled trial of rofecoxib for the acute treatment of migraine
    Tepper, S
    Silberstein, S
    Brandes, J
    Venkatraman, S
    Vrijens, F
    Malbecq, W
    Visser, WH
    Reines, S
    Yuen, E
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 300 - 300
  • [5] Acute migraine treatment with droperidol - A randomized, double-blind, placebo-controlled trial
    Silberstein, SD
    Young, WB
    Mendizabal, JE
    Rothrock, JF
    Alam, AS
    NEUROLOGY, 2003, 60 (02) : 315 - 321
  • [6] Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study
    Yuan, Hsiangkuo
    Curran, John G.
    Keith, Scott W.
    Hopkins, Mary M.
    Silberstein, Stephen D.
    HEADACHE, 2021, 61 (09): : 1432 - 1440
  • [7] Intravenous Ibuprofen for Acute Migraine Treatment: A Double-Blind Randomized Placebo-Controlled Pilot Study
    Curran, John
    Yuan, Hsiangkuo
    Keith, Scott
    Hopkins, Mary
    Silbertstein, Stephen
    NEUROLOGY, 2022, 98 (18)
  • [8] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [9] Efficacy of phenazone in the treatment of acute migraine attacks:: a double-blind, placebo-controlled, randomized study
    Göbel, H
    Heinze, A
    Niederberger, U
    Witt, T
    Zumbroich, V
    CEPHALALGIA, 2004, 24 (10) : 888 - 893
  • [10] A randomized, double-blind, placebo-controlled study of oral almotriptan 6.25 mg, 12.5 mg, and 25 mg in the acute treatment of migraine in adolescents
    Linder, S. L.
    Mathew, N. T.
    Cady, R. K.
    Finlayson, G.
    Ishkanian, G.
    Lewis, D. W.
    Cabarrocas, X.
    ANNALS OF NEUROLOGY, 2006, 60 : S152 - S152
12345